On the day that public comments were due to CMS on its proposed rule that would require the controversial public release of rates hospitals negotiated with health plans, Joe Fifer, president and CEO of HFMA, and Chad Mulvany, director of health finance policy and analysis for HFMA, preview their comments to CMS. Learn about the promise and peril of the approach CMS is taking to this key transparency issue.

Special Episode: CMS Transparency Effort Misses the Mark

The Healthcare Financial Management Association provides industry insights and in-depth stories about hot topics in healthcare finance. Experts weigh in on the latest in healthcare finance policy and practice, and healthcare insiders discuss the most pressing issues facing the industry. podcast@hfma.org

Business

Investing

Careers

Management & Marketing

Business News

Shopping

News

News Commentary

Dr. Vishnukamal Golla discusses the challenges facing primary care physicians and their patients. News team Nick Hut and Shawn Stack provide an update on the Change Healthcare cyberattack and other current events.

Mentioned in this episode:
Multiple GA hospitals accused of not complying with Price Transparency Rule

The "dystopian" state of primary care

The February cyberattack on Change Healthcare, a unit of UnitedHealth Group, continues to cause concern and frustration for providers. In this episode, HFMA Senior Editor Nick Hut and Policy Director Shawn Stack discuss the latest developments, and Joshua Corman, founder of cybersecurity organization I Am the Cavalry, shares insights on what should come next in healthcare.

What the Change Healthcare cyberattack means for the future of the industry

GLP-1 agonists, medications originally formulated to treat diabetes, have gained traction as prescription drugs for weight loss. On this episode, medical researcher and patient advocate Ragen Chastain discusses what healthcare providers should be sharing with their patients about the risks and efficacy of Wegovy and Zepbound.

The hidden risks of weight loss drugs

Chad Mulvany, vice president of federal policy for the California Hospital Association and former HFMA policy director, discusses Bloomberg Philanthropies $250 million investment in the future healthcare workforce, as well as what will actually move the needle on price transparency.

Discussed in this episode:
‘Healthcare High’ coming to Woodside
Northwell, NYC Public Schools announce Northwell School of Health Sciences
The fight for transparency health care prices in America

Healthcare Blame Game: Bloomberg Philanthropies puts $250 million into educating new healthcare workers while Patient Rights Advocate spends on spreading misinformation

This week, we're sharing an episode of our other podcast, Healthcare Blame Game. Patient Rights Advocate (PRA) has engaged hip hop artists like Fat Joe, Busta Rhymes and Method Man in its “Power to the Patients” campaign, claiming that regulations around price transparency are not being enforced, allowing hospitals to hide their prices and “charge whatever they want.” On this episode, HFMA Policy Director Shawn Stack and Ruth Lande, vice president of hospital relations at RIP Medical Debt, discuss PRA’s misinterpretation of price transparency regulations and hospital pricing.
Mentioned in this episode:
Power to the Patients: Fat Joe Public Service Announcement
PatientRightsAdvocate.org misinterprets CMS rules in low estimate of hospital price transparency compliance
Patient Rights Advocate continues to misinterpret price transparency data with latest report
Healthcare Blame Game: Why CFOs should build media relationships
Do you have feedback on an episode or an idea for the Blame Game team? Email us here.

Bonus! Healthcare Blame Game: Patient Rights Advocate’s distortion of price transparency regulations and data, and the ad campaign that’s catching attention

Special Episode: CMS Transparency Effort Misses the Mark

Download our free app to listen on your phone